Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.
about
Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interactionGalactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissuePlasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon productionSiglecs and immune regulationEBI2 is a negative regulator of type I interferons in plasmacytoid and myeloid dendritic cellsPlasmacytoid dendritic cells and type I IFN: 50 years of convergent historyDendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sitesProtein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic CellsPlasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual.Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus.BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cellsThe immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production.Plasmacytoid dendritic cells take up opsonized antigen leading to CD4+ and CD8+ T cell activation in vivo.DAP12 deficiency in liver allografts results in enhanced donor DC migration, augmented effector T cell responses and abrogation of transplant tolerance.In vivo conversion of BM plasmacytoid DC into CD11b+ conventional DC during virus infection.Deciphering the role of DC subsets in MCMV infection to better understand immune protection against viral infectionsSignaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cellsConstitutive expression of TNF-related activation-induced cytokine (TRANCE)/receptor activating NF-κB ligand (RANK)-L by rat plasmacytoid dendritic cells.Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model.Siglec-mediated regulation of immune cell function in disease.Cell depletion in mice that express diphtheria toxin receptor under the control of SiglecH encompasses more than plasmacytoid dendritic cellsThe kinetics of plasmacytoid dendritic cell accumulation in the pancreas of the NOD mouse during the early phases of insulitis.Interleukin-2 inhibits FMS-like tyrosine kinase 3 receptor ligand (flt3L)-dependent development and function of conventional and plasmacytoid dendritic cellsRelative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation.Absence of Siglec-H in MCMV infection elevates interferon alpha production but does not enhance viral clearancePlasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections.Plasmacytoid dendritic cell dichotomy: identification of IFN-α producing cells as a phenotypically and functionally distinct subset.The immunoreceptor adapter protein DAP12 suppresses B lymphocyte-driven adaptive immune responses.Plasmacytoid dendritic cells and the control of herpesvirus infections.The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells.The Role of Dendritic Cell Subsets and Innate Immunity in the Pathogenesis of Type 1 Diabetes and Other Autoimmune Diseases.Sex differences in murine susceptibility to systemic viral infectionsDistinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity.Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis.Plasmacytoid dendritic cells in atherosclerosis.Siglec-H protects from virus-triggered severe systemic autoimmunity.TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release.Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cellsNK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27.
P2860
Q24309134-3EB4F95F-B560-4BD2-8530-5B491FCEAEF0Q24622257-3A894B89-E0AC-4E0F-A14B-6907EB67ABDCQ24676710-42A9DA0E-49BB-4B30-B580-E583B2D6642AQ26992091-C38F42CB-49A7-4B80-91AB-6DE1A91A108EQ27339798-62CDE5BB-9935-4359-9CD6-5553D21880A6Q27485637-26ED95FD-D507-4644-8BA6-BB8FFCEEF79EQ28390013-AF1BB1B7-47A5-4562-859D-4E6BA4F8E2A0Q28771472-865355E8-218B-4207-80B2-A6A846B6D95DQ30422031-1C8596BF-704C-4491-B867-ABDEA4DD0D9EQ30433488-9E970775-C933-4B15-AC6D-17D091CE37A6Q33298653-B156CA31-42EC-4C9C-9AFF-A79D9638B4D8Q33769011-EC630DA0-F1B0-4B43-9A92-5D6FB9BF0A93Q33907906-8D42C9AE-0B06-4DE5-9782-E20869E8D129Q33934101-594488BE-DC61-43AE-AF62-0C3ADC1F8E05Q33964570-0F6D3392-7269-4537-BCBA-BBB34550FDEDQ33965560-C2653E0E-34A5-4973-B284-03F88A9F86E1Q34055580-E8FD2C85-579D-4B42-A154-8D84BC16D2EEQ34201118-0DCC3060-E51D-4B94-AB1F-ED9358B17B94Q34230589-485B7ADA-6FE3-4177-BD9B-7A7FBB1A2862Q34314957-892ED601-13F6-4E0F-B8CC-50EDD5C42CECQ34324493-731AF030-26A0-45D6-B954-063E6C899080Q34571554-C6BF4EF5-3990-4A77-A379-92E3260E2DCDQ34572876-50D08D71-FD60-4641-A40C-2C3E2A6419D9Q34903504-B4FE181C-510D-4E10-A06C-06C9E5A32E10Q35004470-9E4418C2-99AB-48D6-B8ED-F749AEE8A761Q35034249-0414708A-9192-4F6B-85B2-AAE65418CCFFQ35112388-EF16537E-E0CA-44C4-B7CF-2A6ED7672CC0Q35144618-2605909A-AB44-471F-AE26-BB4D51962150Q35259804-25FF22BA-957E-40F1-BF90-7EB1E5720F1FQ35640941-F09D6159-17D4-4A86-8B40-C8165B9977F9Q35739662-4DF3FB80-C43D-4F05-B763-4C27F8EE4359Q35854777-2E31BADC-0ECE-402A-BABD-AE42C5D28A05Q35950210-A9D47C73-87E8-4F79-8758-4C943A6D5103Q36045739-F9749424-29AF-4EBA-B9A2-699628AEDAC7Q36064574-2EA75FB5-A2D4-4F2C-AAD2-7C6EA9C03CA7Q36067728-62504935-8475-4ADF-B18E-91060C84AF3EQ36087376-75C21C53-3E86-46E3-8F1D-1E861DB6B9D6Q36229116-C42A7297-B5A5-4CCB-9497-9D07E568EC71Q36229299-FFC33BB1-108E-4AFE-B8B6-96312AA4BD87Q36293523-4676734B-04C9-4FE5-83D4-CE68976B9D44
P2860
Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.
@en
type
label
Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.
@en
prefLabel
Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.
@en
P2093
P2860
P1433
P1476
Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12.
@en
P2093
Amanda L Blasius
Jorge Maldonado
Toshiyuki Takai
P2860
P304
P356
10.1182/BLOOD-2005-09-3746
P407
P577
2005-11-17T00:00:00Z